Menzel Garry E's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jul 10, 2023
- Accession no.
- 0001104659-23-079700
- Filed
- Jul 10, 2023
- Trade date
- Jul 10, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $43.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Menzel Garry ECIK 0001556064 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −47,702 | $0.91 | −$43,408.82 | 75,056 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.